Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARS Pharmaceuticals
Marketing
ARS Pharma TV ad for Neffy needled by FDA in untitled letter
Months after sending a letter to ARS taking issue with aspects of a TV ad, the FDA is reiterating its concerns about Neffy’s advertising language.
Andrea Park
Jan 29, 2026 11:44am
ARS inks ex-US licensing pact for Neffy worth up to $465M
Nov 11, 2024 9:44am
ARS has 'blue sky opportunity' in launching neffy, analyst says
Aug 21, 2024 12:48pm
ARS hits major setback in bid to launch epinephrine newcomer
Sep 20, 2023 10:31am
FDA accepts ARS' filing for nasal spray EpiPen rival for review
Oct 25, 2022 10:27am
ARS inks reverse merger to get epinephrine nasal spray to market
Jul 26, 2022 10:22am
